vimarsana.com
Home
Live Updates
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall Of
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall Of
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall Of Docetaxel Injection, USP Due To Potential Presence Of Particulate Matter
SCHAUMBURG, Ill., May 28, 2024 /PRNewswire/ -- Sagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Inject
Related Keywords
,
Sagent Pharmaceuticals ,
Drug Administration ,
Fedex ,
Prnewswire Sagent Pharmaceuticals ,
Docetaxel Injection ,
User Level ,
Expiration Dates ,
Medical Affairs ,
Watch Adverse Event Reporting ,